Psychemedics Corporation announced that Sarah Ashby has rejoined the company as Vice President, General Counsel. In this important role, Sarah will be responsible for directing and managing all of the company’s legal activities. She will report directly to the company’s CEO. Sarah rejoins Psychemedics from Decibel Therapeutics Inc. and Takeda Pharmaceutical Company Ltd. In the past four years, she has worked closely with the R&D teams at those organizations in the areas of toxicology studies, clinical trials, research collaborations and contract negotiations. Previously, Sarah practiced at the Boston firms of Campbell Campbell Edwards & Conroy PC, and Wilmer Cutler Pickering Hale & Dorr LLP. Her litigation background includes pharmaceutical and medical device liability, as well as health care fraud investigations, FDA regulation and intellectual property.